Pharmaceuticals
Israeli PolyPid signs $320 million deal to sell drug preventing surgical infections in US, Canada
D-PLEX100 is designed to provide local, prolonged, and controlled antibacterial activity directly at the surgical site to prevent abdominal surgical site infections.
Europe, Israel, and the medical record of a nation - opinion
How Evogene is changing the future for the pharma and agriculture markets
Taking too many medications may harm older adults, study warns
Pfizer, AstraZeneca help launch 'computational science' lab in Israel
A partnership between six leading tech and pharma companies wants to create and adopt new AI technologies that could transform the process of drug discovery and development.
Breakthrough treatment for Tay-Sachs shows positive results, study finds
Tay-Sachs is an inherited disorder that is almost always fatal and disproportionately affects Ashkenazi Jews. Currently, there is no viable medical treatment available.
Shufersal to pay trans woman nearly $10K after pharmacist misgendered her
The pharmacist claimed that they identified Isabel, who dressed in women's clothing and used female pronouns, as a man "by their voice."
Israeli medical cannabis firm Univo acquires pharmacy Medipharm
The acquisition of Medipharm is a step in Univo's strategy of becoming an independent company with complete control over the production chain of medical cannabis.
NeuroRx set for $1.5b. SPAC IPO on Nasdaq
The company will have an estimated post-transaction value of more than $1.5 billion, the Haifa-based company said.
Meuhedet to offer prescription delivery
Meuhedet signed a long-term agreement to cooperate with Epharma, an online pharmacy, to enable members to order prescriptions.
Israeli researchers aim to find ‘cure for the incurable’ to prolong life
"Nothing less than a paradigm shift"
Interest in renting offices high after COVID decline
In the new office complex O-TECH, negotiations are currently underway with a number of international and Israeli companies for renting offices in an area of tens of thousands of square meters.
Father of cannabis research plans a new revolution nearly 60 years later
"The more we checked, the more we saw that we have a new potential alternative to probably two of the most horrible diseases you can find today."
Merck says study shows COVID-19 drug causes quick reduction in virus
The drug was first tested in Israel, after Sheba Medical Center signed a deal to become the first hospital in the world to participate in the trial.
